<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PSC Quick Reference</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --primary: #2c3e50;
            --secondary: #3498db;
            --danger: #e74c3c;
            --warning: #f39c12;
            --success: #2ecc71;
            --light: #ecf0f1;
            --dark: #34495e;
            --border-radius: 8px;
            --transition: all 0.3s ease;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }

        body {
            background-color: #f5f7fa;
            color: var(--dark);
            line-height: 1.6;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }

        header {
            background-color: var(--primary);
            color: white;
            padding: 15px 20px;
            border-radius: var(--border-radius);
            margin-bottom: 20px;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        h1 {
            font-size: 1.8rem;
        }

        .subtitle {
            font-size: 0.9rem;
            opacity: 0.8;
        }

        .tabs {
            display: flex;
            margin-bottom: 20px;
            background-color: white;
            border-radius: var(--border-radius);
            overflow: hidden;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
        }

        .tab {
            flex: 1;
            padding: 12px 15px;
            text-align: center;
            cursor: pointer;
            transition: var(--transition);
            border: none;
            background: none;
            font-size: 0.9rem;
        }

        .tab:hover {
            background-color: #f0f0f0;
        }

        .tab.active {
            background-color: var(--secondary);
            color: white;
        }

        .content {
            display: none;
        }

        .content.active {
            display: block;
            animation: fadeIn 0.5s;
        }

        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }

        .card-container {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(300px, 1fr));
            gap: 20px;
            margin-bottom: 20px;
        }

        .card {
            background-color: white;
            border-radius: var(--border-radius);
            padding: 20px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.05);
            transition: var(--transition);
            height: 100%;
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
        }

        .card-header {
            display: flex;
            align-items: center;
            margin-bottom: 15px;
            border-bottom: 1px solid #eee;
            padding-bottom: 10px;
        }

        .card-icon {
            margin-right: 10px;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
        }

        .danger {
            border-left: 5px solid var(--danger);
        }

        .danger .card-icon {
            color: var(--danger);
        }

        .warning {
            border-left: 5px solid var(--warning);
        }

        .warning .card-icon {
            color: var(--warning);
        }

        .success {
            border-left: 5px solid var(--success);
        }

        .success .card-icon {
            color: var(--success);
        }

        .info {
            border-left: 5px solid var(--secondary);
        }

        .info .card-icon {
            color: var(--secondary);
        }

        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
        }

        .table-container {
            overflow-x: auto;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 10px;
        }

        th, td {
            padding: 10px;
            text-align: left;
            border-bottom: 1px solid #ddd;
        }

        th {
            background-color: #f2f2f2;
            font-weight: 600;
        }

        .alert {
            padding: 15px;
            border-radius: var(--border-radius);
            margin-bottom: 20px;
            display: flex;
            align-items: center;
        }

        .alert-icon {
            margin-right: 10px;
            font-size: 1.2rem;
        }

        .alert-danger {
            background-color: rgba(231, 76, 60, 0.1);
            border-left: 5px solid var(--danger);
        }

        .alert-danger .alert-icon {
            color: var(--danger);
        }

        .alert-success {
            background-color: rgba(46, 204, 113, 0.1);
            border-left: 5px solid var(--success);
        }

        .alert-success .alert-icon {
            color: var(--success);
        }

        .action-btn {
            display: inline-block;
            padding: 8px 15px;
            border-radius: var(--border-radius);
            text-decoration: none;
            font-weight: 500;
            transition: var(--transition);
            margin-right: 10px;
            margin-bottom: 10px;
        }

        .action-danger {
            background-color: var(--danger);
            color: white;
        }

        .action-danger:hover {
            background-color: #c0392b;
        }

        .action-success {
            background-color: var(--success);
            color: white;
        }

        .action-success:hover {
            background-color: #27ae60;
        }

        .action-info {
            background-color: var(--secondary);
            color: white;
        }

        .action-info:hover {
            background-color: #2980b9;
        }

        .expandable {
            margin-top: 10px;
        }

        .expandable-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            cursor: pointer;
            padding: 10px;
            background-color: #f5f5f5;
            border-radius: var(--border-radius);
        }

        .expandable-content {
            padding: 15px;
            display: none;
        }

        .expandable.active .expandable-content {
            display: block;
        }

        .expandable.active .expandable-header i {
            transform: rotate(180deg);
        }

        .expandable-header i {
            transition: var(--transition);
        }

        .progress-container {
            margin: 20px 0;
        }

        .progress-label {
            display: flex;
            justify-content: space-between;
            margin-bottom: 5px;
        }

        .progress-bar {
            height: 10px;
            background-color: #eee;
            border-radius: 5px;
            overflow: hidden;
        }

        .progress {
            height: 100%;
            background-color: var(--secondary);
        }

        .timeline {
            position: relative;
            margin: 20px 0;
        }

        .timeline::before {
            content: '';
            position: absolute;
            top: 0;
            left: 30px;
            height: 100%;
            width: 2px;
            background-color: #eee;
        }

        .timeline-item {
            position: relative;
            padding-left: 70px;
            margin-bottom: 20px;
        }

        .timeline-icon {
            position: absolute;
            left: 20px;
            top: 0;
            width: 20px;
            height: 20px;
            border-radius: 50%;
            background-color: var(--secondary);
            color: white;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 0.8rem;
        }

        .timeline-content {
            background-color: white;
            padding: 15px;
            border-radius: var(--border-radius);
            box-shadow: 0 2px 5px rgba(0,0,0,0.05);
        }

        .timeline-title {
            font-weight: 600;
            margin-bottom: 5px;
        }

        .timeline-description {
            font-size: 0.9rem;
            color: #666;
        }

        .search-box {
            position: relative;
            margin-bottom: 20px;
        }

        .search-input {
            width: 100%;
            padding: 10px 40px 10px 15px;
            border: 1px solid #ddd;
            border-radius: var(--border-radius);
            font-size: 1rem;
        }

        .search-icon {
            position: absolute;
            right: 15px;
            top: 50%;
            transform: translateY(-50%);
            color: #aaa;
        }

        .highlight {
            background-color: rgba(255, 236, 179, 0.5);
            padding: 2px 4px;
            border-radius: 3px;
        }

        .tooltip {
            position: relative;
            display: inline-block;
            border-bottom: 1px dotted #333;
            cursor: help;
        }

        .tooltip-text {
            visibility: hidden;
            width: 200px;
            background-color: var(--dark);
            color: white;
            text-align: center;
            border-radius: var(--border-radius);
            padding: 10px;
            position: absolute;
            z-index: 1;
            bottom: 125%;
            left: 50%;
            transform: translateX(-50%);
            opacity: 0;
            transition: opacity 0.3s;
        }

        .tooltip:hover .tooltip-text {
            visibility: visible;
            opacity: 1;
        }

        .footer {
            margin-top: 30px;
            padding: 15px;
            text-align: center;
            font-size: 0.8rem;
            color: #666;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .two-column {
                grid-template-columns: 1fr;
            }
            
            .tabs {
                flex-direction: column;
            }
            
            .timeline::before {
                left: 15px;
            }
            
            .timeline-item {
                padding-left: 40px;
            }
            
            .timeline-icon {
                left: 5px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <div>
                <h1>Primary Sclerosing Cholangitis</h1>
                <div class="subtitle">Quick Reference Guide</div>
            </div>
            <div>
                <i class="fas fa-liver fa-2x"></i>
            </div>
        </header>

        <div class="search-box">
            <input type="text" class="search-input" id="searchInput" placeholder="Search for keywords...">
            <i class="fas fa-search search-icon"></i>
        </div>

        <div class="tabs">
            <button class="tab active" data-tab="overview">Overview</button>
            <button class="tab" data-tab="diagnosis">Diagnosis</button>
            <button class="tab" data-tab="management">Management</button>
            <button class="tab" data-tab="complications">Complications</button>
            <button class="tab" data-tab="monitoring">Monitoring</button>
        </div>

        <div id="overview" class="content active">
            <div class="alert alert-danger">
                <i class="fas fa-exclamation-triangle alert-icon"></i>
                <div>
                    <strong>Emergency:</strong> Sudden deterioration in clinical status or biochemical tests may indicate dominant stricture or cholangiocarcinoma. Immediate evaluation required.
                </div>
            </div>

            <div class="card-container">
                <div class="card danger">
                    <div class="card-header">
                        <i class="fas fa-exclamation-circle card-icon"></i>
                        <div class="card-title">Red Flags</div>
                    </div>
                    <ul>
                        <li>Sudden worsening pruritus, fevers, and jaundice</li>
                        <li>Rapid increase in alkaline phosphatase</li>
                        <li>Weight loss and decreased appetite</li>
                        <li>New onset abdominal pain</li>
                        <li>Signs of liver failure (ascites, encephalopathy)</li>
                    </ul>
                </div>

                <div class="card info">
                    <div class="card-header">
                        <i class="fas fa-info-circle card-icon"></i>
                        <div class="card-title">Key Facts</div>
                    </div>
                    <ul>
                        <li>Cholestatic liver disease causing bile duct destruction</li>
                        <li>Predominantly affects young and middle-aged men</li>
                        <li>50-80% have associated inflammatory bowel disease</li>
                        <li>May be asymptomatic at diagnosis</li>
                        <li>No effective medical therapy available</li>
                    </ul>
                </div>

                <div class="card warning">
                    <div class="card-header">
                        <i class="fas fa-user-friends card-icon"></i>
                        <div class="card-title">At Risk Population</div>
                    </div>
                    <ul>
                        <li>Male (2:1 male-to-female ratio)</li>
                        <li>Age 25-45 years (median 36-39)</li>
                        <li>Patients with IBD (especially ulcerative colitis)</li>
                        <li>First-degree relatives of PSC patients</li>
                    </ul>
                </div>

                <div class="card success">
                    <div class="card-header">
                        <i class="fas fa-check-circle card-icon"></i>
                        <div class="card-title">Positive Actions</div>
                    </div>
                    <ul>
                        <li>Screen all IBD patients with annual liver function tests</li>
                        <li>Refer advanced cases to liver transplantation center</li>
                        <li>Colonoscopy surveillance for colorectal cancer</li>
                        <li>Bone mineral density scanning at diagnosis</li>
                    </ul>
                </div>
            </div>

            <div class="two-column">
                <div class="card">
                    <div class="card-header">
                        <i class="fas fa-stethoscope card-icon"></i>
                        <div class="card-title">Common Presentations</div>
                    </div>
                    <table>
                        <tr>
                            <th>Symptom</th>
                            <th>Frequency</th>
                        </tr>
                        <tr>
                            <td>Asymptomatic</td>
                            <td>~50%</td>
                        </tr>
                        <tr>
                            <td>Pruritus</td>
                            <td>30-60%</td>
                        </tr>
                        <tr>
                            <td>Abdominal pain</td>
                            <td>20-30%</td>
                        </tr>
                        <tr>
                            <td>Fatigue</td>
                            <td>6-17%</td>
                        </tr>
                        <tr>
                            <td>Weight loss</td>
                            <td>Variable</td>
                        </tr>
                        <tr>
                            <td>Jaundice</td>
                            <td>6-27%</td>
                        </tr>
                        <tr>
                            <td>Fever</td>
                            <td>4-11%</td>
                        </tr>
                    </table>
                </div>

                <div class="card">
                    <div class="card-header">
                        <i class="fas fa-microscope card-icon"></i>
                        <div class="card-title">PSC Variants</div>
                    </div>
                    <ul>
                        <li><strong>Large-duct PSC:</strong> Classic form involving intra- and extrahepatic ducts visible on cholangiography</li>
                        <li><strong>Small-duct PSC:</strong> Affects only small bile ducts (normal cholangiography, abnormal histology)</li>
                        <li><strong>PSC-AIH overlap:</strong> Features of autoimmune hepatitis with cholangiographic abnormalities</li>
                    </ul>
                </div>
            </div>
        </div>

        <div id="diagnosis" class="content">
            <div class="card-container">
                <div class="card danger">
                    <div class="card-header">
                        <i class="fas fa-exclamation-triangle card-icon"></i>
                        <div class="card-title">Diagnostic Red Flags</div>
                    </div>
                    <ul>
                        <li>Alkaline phosphatase > 3x upper limit of normal</li>
                        <li>Marked elevation in aminotransferases (>5x ULN) suggests overlap with autoimmune hepatitis</li>
                        <li>IgG4 > 5.6 g/L suggests IgG4-associated disease</li>
                        <li>Normal cholangiogram with typical biochemical/histological findings suggests small-duct PSC</li>
                    </ul>
                </div>

                <div class="card info">
                    <div class="card-header">
                        <i class="fas fa-vial card-icon"></i>
                        <div class="card-title">Key Laboratory Findings</div>
                    </div>
                    <table>
                        <tr>
                            <th>Test</th>
                            <th>Typical Result</th>
                        </tr>
                        <tr>
                            <td>Alkaline phosphatase</td>
                            <td>Elevated in most patients</td>
                        </tr>
                        <tr>
                            <td>Gamma-GT</td>
                            <td>Elevated</td>
                        </tr>
                        <tr>
                            <td>Aminotransferases</td>
                            <td>Mild to moderate elevation</td>
                        </tr>
                        <tr>
                            <td>Bilirubin</td>
                            <td>Normal or elevated</td>
                        </tr>
                        <tr>
                            <td>Albumin</td>
                            <td>Normal in early disease</td>
                        </tr>
                        <tr>
                            <td>IgG4</td>
                            <td>Normal or elevated</td>
                        </tr>
                    </table>
                </div>
            </div>

            <div class="two-column">
                <div class="card">
                    <div class="card-header">
                        <i class="fas fa-x-ray card-icon"></i>
                        <div class="card-title">Imaging Approach</div>
                    </div>
                    <div class="timeline">
                        <div class="timeline-item">
                            <div class="timeline-icon"><i class="fas fa-1"></i></div>
                            <div class="timeline-content">
                                <div class="timeline-title">Abdominal Ultrasound</div>
                                <div class="timeline-description">Initial non-invasive test to investigate for abnormal bile ducts and stones</div>
                            </div>
                        </div>
                        <div class="timeline-item">
                            <div class="timeline-icon"><i class="fas fa-2"></i></div>
                            <div class="timeline-content">
                                <div class="timeline-title">MRCP</div>
                                <div class="timeline-description">Preferred diagnostic test showing multi-focal stricturing and dilation</div>
                            </div>
                        </div>
                        <div class="timeline-item">
                            <div class="timeline-icon"><i class="fas fa-3"></i></div>
                            <div class="timeline-content">
                                <div class="timeline-title">ERCP</div>
                                <div class="timeline-description">Only if MRCP non-diagnostic or therapeutic intervention needed</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="card">
                    <div class="card-header">
                        <i class="fas fa-search card-icon"></i>
                        <div class="card-title">Diagnostic Criteria</div>
                    </div>
                    <ul>
                        <li>Cholangiography with multi-focal stricturing of intra- and/or extrahepatic bile ducts</li>
                        <li>Biochemical evidence of cholestasis</li>
                        <li>Exclusion of secondary causes</li>
                    </ul>
                    <div class="expandable">
                        <div class="expandable-header">
                            <span>Histological Staging</span>
                            <i class="fas fa-chevron-down"></i>
                        </div>
                        <div class="expandable-content">
                            <ul>
                                <li>Stage 1: Bile duct injury and portal inflammation with minimal fibrosis</li>
                                <li>Stage 2: Expansion of portal tracts, periportal fibrosis</li>
                                <li>Stage 3: Fibrous septa, bridging fibrosis, ductopenia</li>
                                <li>Stage 4: Cirrhosis</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div id="management" class="content">
            <div class="alert alert-success">
                <i class="fas fa-check-circle alert-icon"></i>
                <div>
                    <strong>Management Approach:</strong> Treat symptoms and complications, with liver transplantation for end-stage liver disease. Consider all patients for clinical trials.
                </div>
            </div>

            <div class="card-container">
                <div class="card success">
                    <div class="card-header">
                        <i class="fas fa-pills card-icon"></i>
                        <div class="card-title">Medical Management</div>
                    </div>
                    <ul>
                        <li>No effective medical therapy available</li>
                        <li>Ursodeoxycholic acid (UDCA) may improve biochemistry but no proven survival benefit</li>
                        <li>Immunosuppressors not effective for classic PSC</li>
                        <li>Corticosteroids only for PSC-AIH overlap or IgG4-associated disease</li>
                    </ul>
                </div>

                <div class="card warning">
                    <div class="card-header">
                        <i class="fas fa-procedures card-icon"></i>
                        <div class="card-title">Endoscopic Management</div>
                    </div>
                    <ul>
                        <li>Dominant strictures: balloon dilation with or without stenting</li>
                        <li>Bacterial cholangitis: biliary drainage and antibiotics</li>
                        <li>Bile duct stones: extraction</li>
                        <li>Brush cytology/FISH for cholangiocarcinoma surveillance</li>
                    </ul>
                </div>

                <div class="card info">
                    <div class="card-header">
                        <i class="fas fa-heartbeat card-icon"></i>
                        <div class="card-title">Transplantation</div>
                    </div>
                    <ul>
                        <li>Only treatment option for advanced disease</li>
                        <li>Indications: decompensated cirrhosis, recurrent cholangitis, intractable pruritus</li>
                        <li>5-year survival post-transplant: 85-90%</li>
                        <li>Recurrence in 20-25% of transplanted patients</li>
                    </ul>
                </div>
            </div>

            <div class="card">
                <div class="card-header">
                    <i class="fas fa-sitemap card-icon"></i>
                    <div class="card-title">Management Algorithm</div>
                </div>
                <div class="progress-container">
                    <div class="progress-label">
                        <span>Initial Assessment</span>
                        <span>100%</span>
                    </div>
                    <div class="progress-bar">
                        <div class="progress" style="width: 100%;"></div>
                    </div>
                </div>
                <div class="timeline">
                    <div class="timeline-item">
                        <div class="timeline-icon"><i class="fas fa-1"></i></div>
                        <div class="timeline-content">
                            <div class="timeline-title">Confirm Diagnosis</div>
                            <div class="timeline-description">MRCP, laboratory tests, exclude secondary causes</div>
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-icon"><i class="fas fa-2"></i></div>
                        <div class="timeline-content">
                            <div class="timeline-title">Assess Disease Stage</div>
                            <div class="timeline-description">Fibrosis staging, dominant strictures, cholangiocarcinoma screening</div>
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-icon"><i class="fas fa-3"></i></div>
                        <div class="timeline-content">
                            <div class="timeline-title">Manage Symptoms</div>
                            <div class="timeline-description">Pruritus (cholestyramine), fat malabsorption, nutritional support</div>
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-icon"><i class="fas fa-4"></i></div>
                        <div class="timeline-content">
                            <div class="timeline-title">Treat Complications</div>
                            <div class="timeline-description">Dominant strictures, cholangitis, cholangiocarcinoma</div>
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-icon"><i class="fas fa-5"></i></div>
                        <div class="timeline-content">
                            <div class="timeline-title">Monitor Progression</div>
                            <div class="timeline-description">Regular LFTs, imaging, surveillance for complications</div>
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-icon"><i class="fas fa-6"></i></div>
                        <div class="timeline-content">
                            <div class="timeline-title">Refer for Transplant</div>
                            <div class="timeline-description">When advanced disease or complications develop</div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div id="complications" class="content">
            <div class="alert alert-danger">
                <i class="fas fa-exclamation-triangle alert-icon"></i>
                <div>
                    <strong>Major Complications:</strong> Liver failure and cholangiocarcinoma are the leading causes of death in PSC patients.
                </div>
            </div>

            <div class="card-container">
                <div class="card danger">
                    <div class="card-header">
                        <i class="fas fa-exclamation-circle card-icon"></i>
                        <div class="card-title">Cholangiocarcinoma</div>
                    </div>
                    <ul>
                        <li>Occurs in 7-15% of PSC patients</li>
                        <li>Risk increases with disease duration</li>
                        <li>Difficult to diagnose early</li>
                        <li>Poor prognosis (median survival < 12 months)</li>
                        <li>Surveillance with CA 19-9 and imaging recommended</li>
                    </ul>
                </div>

                <div class="card warning">
                    <div class="card-header">
                        <i class="fas fa-exclamation-triangle card-icon"></i>
                        <div class="card-title">Dominant Strictures</div>
                    </div>
                    <ul>
                        <li>Present in 40-50% of patients</li>
                        <li>Defined as stenosis ≤1.5mm in common bile duct or ≤1mm in hepatic duct</li>
                        <li>Can cause jaundice, pruritus, cholangitis</li>
                        <li>Require endoscopic dilation with or without stenting</li>
                    </ul>
                </div>

                <div class="card info">
                    <div class="card-header">
                        <i class="fas fa-bacteria card-icon"></i>
                        <div class="card-title">Bacterial Cholangitis</div>
                    </div>
                    <ul>
                        <li>Recurrent episodes in 6-15% of patients</li>
                        <li>Present with fever, right upper quadrant pain, jaundice</li>
                        <li>Require antibiotics and biliary drainage</li>
                        <li>ERCP may be needed if not responding to antibiotics</li>
                    </ul>
                </div>

                <div class="card warning">
                    <div class="card-header">
                        <i class="fas fa-bone card-icon"></i>
                        <div class="card-title">Metabolic Complications</div>
                    </div>
                    <ul>
                        <li>Fat malabsorption leading to steatorrhea</li>
                        <li>Fat-soluble vitamin deficiency (A, D, E, K)</li>
                        <li>Osteoporosis (screen at diagnosis and every 2-4 years)</li>
                        <li>Cholestasis-induced pruritus</li>
                    </ul>
                </div>
            </div>

            <div class="card">
                <div class="card-header">
                    <i class="fas fa-chart-line card-icon"></i>
                    <div class="card-title">Risk Assessment</div>
                </div>
                <div class="table-container">
                    <table>
                        <tr>
                            <th>Risk Factor</th>
                            <th>Associated Complication</th>
                            <th>Management</th>
                        </tr>
                        <tr>
                            <td>Disease duration > 10 years</td>
                            <td>Cholangiocarcinoma</td>
                            <td>Annual imaging + CA 19-9</td>
                        </tr>
                        <tr>
                            <td>IBD (especially UC)</td>
                            <td>Colorectal cancer</td>
                            <td>Annual colonoscopy</td>
                        </tr>
                        <tr>
                            <td>Advanced fibrosis/cirrhosis</td>
                            <td>Hepatocellular carcinoma</td>
                            <td>Ultrasound surveillance every 6 months</td>
                        </tr>
                        <tr>
                            <td>Long-standing cholestasis</td>
                            <td>Osteoporosis</td>
                            <td>Bone density scanning every 2-4 years</td>
                        </tr>
                    </table>
                </div>
            </div>
        </div>

        <div id="monitoring" class="content">
            <div class="card-container">
                <div class="card success">
                    <div class="card-header">
                        <i class="fas fa-calendar-check card-icon"></i>
                        <div class="card-title">Follow-up Schedule</div>
                    </div>
                    <div class="table-container">
                        <table>
                            <tr>
                                <th>Assessment</th>
                                <th>Frequency</th>
                            </tr>
                            <tr>
                                <td>Liver function tests</td>
                                <td>Every 6-12 months</td>
                            </tr>
                            <tr>
                                <td>Physical examination</td>
                                <td>Every 6-12 months</td>
                            </tr>
                            <tr>
                                <td>MRCP</td>
                                <td>Every 1-3 years</td>
                            </tr>
                            <tr>
                                <td>Colonoscopy (if IBD)</td>
                                <td>Annually</td>
                            </tr>
                            <tr>
                                <td>Bone density scan</td>
                                <td>Every 2-4 years</td>
                            </tr>
                            <tr>
                                <td>Vitamin D levels</td>
                                <td>Annually</td>
                            </tr>
                        </table>
                    </div>
                </div>

                <div class="card info">
                    <div class="card-header">
                        <i class="fas fa-chart-bar card-icon"></i>
                        <div class="card-title">Disease Progression Monitoring</div>
                    </div>
                    <ul>
                        <li>Transient elastography or magnetic resonance elastography to stage fibrosis</li>
                        <li>Mayo PSC Risk Score for prognosis calculation</li>
                        <li>Serial imaging to detect dominant strictures or cholangiocarcinoma</li>
                        <li>Monitor for symptoms of fat malabsorption and vitamin deficiency</li>
                    </ul>
                </div>
            </div>

            <div class="two-column">
                <div class="card">
                    <div class="card-header">
                        <i class="fas fa-user-check card-icon"></i>
                        <div class="card-title">When to Refer to Transplant Center</div>
                    </div>
                    <ul>
                        <li>Model for End-Stage Liver Disease (MELD) score ≥ 15</li>
                        <li>Refractory bacterial cholangitis</li>
                        <li>Intractable pruritus severely affecting quality of life</li>
                        <li>Recurrent variceal bleeding despite standard therapy</li>
                        <li>Suspected cholangiocarcinoma (for evaluation)</li>
                    </ul>
                </div>

                <div class="card">
                    <div class="card-header">
                        <i class="fas fa-pills card-icon"></i>
                        <div class="card-title">Medication Monitoring</div>
                    </div>
                    <ul>
                        <li>UDCA: Monitor LFTs, dose 13-23 mg/kg/day</li>
                        <li>Cholestyramine: Monitor fat-soluble vitamin levels</li>
                        <li>Rifampin: Monitor LFTs, CBC</li>
                        <li>Vitamin supplements: Monitor levels periodically</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="footer">
            <p>Primary Sclerosing Cholangitis Quick Reference Guide | Based on BMJ Best Practice | Last Updated: November 2025</p>
            <p>This reference tool is for clinical guidance only and should not replace clinical judgment.</p>
        </div>
    </div>

    <script>
        // Tab functionality
        document.addEventListener('DOMContentLoaded', function() {
            const tabs = document.querySelectorAll('.tab');
            const contents = document.querySelectorAll('.content');
            
            tabs.forEach(tab => {
                tab.addEventListener('click', () => {
                    // Remove active class from all tabs and contents
                    tabs.forEach(t => t.classList.remove('active'));
                    contents.forEach(c => c.classList.remove('active'));
                    
                    // Add active class to clicked tab and corresponding content
                    tab.classList.add('active');
                    const tabId = tab.getAttribute('data-tab');
                    document.getElementById(tabId).classList.add('active');
                });
            });
            
            // Expandable sections
            const expandables = document.querySelectorAll('.expandable');
            
            expandables.forEach(expandable => {
                const header = expandable.querySelector('.expandable-header');
                
                header.addEventListener('click', () => {
                    expandable.classList.toggle('active');
                });
            });
            
            // Search functionality
            const searchInput = document.getElementById('searchInput');
            
            searchInput.addEventListener('input', function() {
                const searchTerm = this.value.toLowerCase();
                
                if (searchTerm.length > 2) {
                    // Hide all tabs and contents
                    tabs.forEach(tab => tab.style.display = 'none');
                    contents.forEach(content => content.classList.remove('active'));
                    
                    // Search through all content
                    contents.forEach(content => {
                        const text = content.textContent.toLowerCase();
                        if (text.includes(searchTerm)) {
                            content.classList.add('active');
                            
                            // Show the corresponding tab
                            const contentId = content.getAttribute('id');
                            const correspondingTab = document.querySelector(`[data-tab="${contentId}"]`);
                            if (correspondingTab) {
                                correspondingTab.style.display = 'block';
                                correspondingTab.classList.add('active');
                            }
                        }
                    });
                    
                    // Highlight search terms
                    if (searchTerm.length > 2) {
                        const activeContent = document.querySelector('.content.active');
                        if (activeContent) {
                            const textNodes = getTextNodes(activeContent);
                            textNodes.forEach(node => {
                                const text = node.textContent;
                                const regex = new RegExp(`(${searchTerm})`, 'gi');
                                if (regex.test(text)) {
                                    const span = document.createElement('span');
                                    span.innerHTML = text.replace(regex, '<span class="highlight">$1</span>');
                                    node.parentNode.replaceChild(span, node);
                                }
                            });
                        }
                    }
                } else {
                    // Reset to default view
                    tabs.forEach(tab => {
                        tab.style.display = '';
                        tab.classList.remove('active');
                    });
                    contents.forEach(content => {
                        content.classList.remove('active');
                    });
                    
                    // Show first tab and content
                    tabs[0].classList.add('active');
                    contents[0].classList.add('active');
                    
                    // Remove highlights
                    document.querySelectorAll('.highlight').forEach(highlight => {
                        const parent = highlight.parentNode;
                        parent.replaceChild(document.createTextNode(highlight.textContent), highlight);
                        parent.normalize();
                    });
                }
            });
            
            // Helper function to get text nodes
            function getTextNodes(element) {
                const textNodes = [];
                
                function getTextNodesRecursive(node) {
                    if (node.nodeType === 3) {
                        textNodes.push(node);
                    } else if (node.nodeType === 1 && node.nodeName !== 'SCRIPT' && node.nodeName !== 'STYLE') {
                        for (let i = 0; i < node.childNodes.length; i++) {
                            getTextNodesRecursive(node.childNodes[i]);
                        }
                    }
                }
                
                getTextNodesRecursive(element);
                return textNodes;
            }
        });
    </script>
</body>
</html>